IGF-IR: a new prognostic biomarker for human glioblastoma

BACKGROUND: Glioblastomas (GBMs) are the most common malignant primary brain tumours in adults and are refractory to conventional therapy, including surgical resection, radiotherapy and chemotherapy. The insulin-like growth factor (IGF) system is a complex network that includes ligands (IGFI and IGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Maris, C, D'Haene, N, Trépant, A-L, Le Mercier, M, Sauvage, S, Allard, J, Rorive, S, Demetter, P, Decaestecker, C, Salmon, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559821/
https://www.ncbi.nlm.nih.gov/pubmed/26291053
http://dx.doi.org/10.1038/bjc.2015.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559821/
https://www.ncbi.nlm.nih.gov/pubmed/26291053
http://dx.doi.org/10.1038/bjc.2015.242

Ejemplares similares